Karyopharm Therapeutics Secures $48,200,000 Series B Round

  • Feed Type
  • Date
    5/20/2013
  • Company Name
    Karyopharm Therapeutics
  • Mailing Address
    2 Mercer Road Natick, MA 01760
  • Company Description
    Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
  • Website
    http://www.karyopharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $48,200,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funds will be used to advance the Company’s pipeline of novel Selective Inhibitors of Nuclear Export (SINE) drug candidates for the treatment of advanced hematologic and solid tumors.
  • M&A Terms
  • Venture Investor
    Undisclosed
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.